Severe Hematotoxicity After CD19 CAR-T Therapy Is Associated with Suppressive Immune Dysregulation and Limited CAR-T Expansion

Scientists investigated how CAR T cell expansion dynamics and serum proteomics affected neutrophil recovery phenotypes after CD19-directed CAR T cell therapy.